butolame butolame butolame, also known as 17β-((4-hydroxybutyl)amino)estradiol, is a synthetic, steroidal estrogen and a 17β-aminoestrogen with anticoagulant effects that was first described in 1993 and was never marketed. butolameclinical dataother names17β-((4-hydroxybutyl)amino)estradiol; 17β-estra-1,3,5(10)-trien-3-olidentifiers iupac name (8r,9s,13s,14s,17s)-17-(4-hydroxybutylamino)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopentaphenanthren-3-ol cas number150748-23-5 ypubchem cid197608chemspider171062unii4upr2b5sg4comptox dashboard (epa)dtxsid80934056 chemical and physical dataformulac22h33no2molar mass343.511 g·mol−13d model (jsmol)interactive image smiles c12cc3(1cc2ncccco)ccc4=c3c=cc(=c4)o inchi inchi=1s/c22h33no2/c1-22-11-10-18-17-7-5-16(25)14-15(17)4-6-19(18)20(22)8-9-21(22)23-12-2-3-13-24/h5,7,14,18-21,23-25h,2-4,6,8-13h2,1h3/t18-,19-,20+,21+,22+/m1/s1key:axfqqaqjyixkgs-aanpdwtmsa-n